FX.co ★ DAX Edges Higher

On Wednesday, Frankfurt's DAX index experienced a modest uplift, surpassing the 23,940 mark, primarily driven by gains in the healthcare sector as investors reacted positively to news concerning tariffs. Merck led the charge with a 5.9% increase, followed by Siemens Healthineers at 1.7%, and Bayer, which climbed 1.2%. This uptick came in the wake of an accord between Pfizer and the Trump administration that will facilitate patient access to discounted prescription drugs via a new federal platform. Despite this, the overall market sentiment remained cautious due to the ongoing US government shutdown. Defense stocks faced setbacks, with notable declines in Renk (-4%), Hensoldt (-2.8%), and Rheinmetall (-2.3%). Meanwhile, Eurozone inflation rose to 2.2% in September, aligning with expectations and supporting the European Central Bank’s careful stance on further interest rate cuts.